Results 231 to 240 of about 4,527,801 (246)

Favorable Outcomes and Anti-TNF Durability After Addition of an Immunomodulator for Anti-Drug Antibodies in Pediatric IBD Patients

Inflammatory Bowel Diseases, 2021
Ruben J Colman, Phillip Minar
exaly  

Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates†‡

Ca-A Cancer Journal for Clinicians, 2006
David M Goldenberg, R M Sharkey, Robert M Sharkey   +2 more
exaly  

Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab.

Clinical and Experimental Immunology, 2018
Boris Gorovits, L Marshall
exaly  

Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response

Expert Review of Clinical Immunology, 2013

exaly  

An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug

Journal of Immunological Methods, 2007
Robert J Konrad, Daphne L Farrington
exaly  

Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab

OncoImmunology, 2018
Lars Bastholt, Claus H. Nielsen, Inge Marie Svane   +2 more
exaly  

Journal of Drug Targeting

Journal of Drug Targeting, 2018
Qiang Chen, Yuxi Wang, Yamei Yu
exaly  

Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease

Expert Review of Gastroenterology and Hepatology, 2015
Christina Ha, Asher Kornbluth
exaly  

Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies

Molecular Therapy, 2019
Amber S Zhou, Ronald C Desrosiers, Michael Farzan   +2 more
exaly  

Prediction of natalizumab anti-drug antibodies persistency

Multiple Sclerosis Journal, 2019
Anna Fogdell-Hahn, Finn Sellebjerg, Michael Auer   +2 more
exaly